Icotrokinra vs Pramlintide
Overview
Icotrokinra is primarily a immune support peptide, while Pramlintide is used for weight management & metabolic.
This page compares Icotrokinra and Pramlintide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | Pramlintide | |
|---|---|---|
| Category | Immune Support | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | — | 60-120 mcg |
| Frequency | — | with meals |
| Reported benefits | — | Reduced post-meal glucose, weight loss, appetite control |
| Reported side effects | — | Nausea, hypoglycemia risk with insulin |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while Pramlintide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Icotrokinra: FDA-approved. Pramlintide: FDA-approved.
Dosing. Typical dosing for Icotrokinra is not catalogued. Pramlintide is typically dosed at 60-120 mcg (with meals).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and Pramlintide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and Pramlintide?
- Icotrokinra is primarily a immune support peptide, while Pramlintide is used for weight management & metabolic. Icotrokinra is FDA-approved for one or more indications, whereas Pramlintide is FDA-approved for one or more indications.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is Pramlintide used for?
- Amylin analog for diabetes.
- Can you take Icotrokinra and Pramlintide together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and Pramlintide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or Pramlintide FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. Pramlintide is FDA-approved for one or more indications.
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- Pramlintide — full monograph: mechanism, research, dosing & references